 However, the Court did, then, appear to approve the " clear prima facie error " approach where the applicant for leave had been unsuccessful after two hearings and questions of fact, impression and judgment were involved: see Pfizer at [12].
 First, in the "findings" section of her Honour's reasons for that decision, the primary judge began by stating " In my view the fourth and fifth affidavits are not admissible ": see [2008] FCA 378 at [11] .
 In the process, she observed that it contained: " vague references (for example, with respect to use of the trademarks in paras 10 and 11 ...), possible inaccuracies (for example, in para 16 ...), opinion evidence (for example, para 17 ...) ... ": see at [13].
